Eur Respir J 1996; 9: 307-312
Copyright © ERS Journals Ltd 1996
Oxidized BAL fluid proteins in patients with interstitial lung diseases
AG Lenz,
U Costabel,
and
KL Maier
Oxygen-derived free radicals, released by phagocytic cells, have been postulated to contribute to lung tissue damage. We therefore investigated oxidative damage to proteins from bronchoalveolar lavage fluid (BALF) as an indicator of oxidative stress and to assess antioxidant defences in the lungs. We examined BAL fluids from patients with interstitial lung diseases, such as idiopathic pulmonary fibrosis (IPF, nonsmokers (NS) and smokers (S)), sarcoidosis (SARC, nonsmokers), and asbestosis (ASB, ex-smokers (EXS)). The oxidation of BALF proteins is accompanied by the introduction of carbonyl groups into their amino acid side-chains and can be quantitated by labeling these groups with tritiated borohydride. The total lung content of oxidized proteins recovered by bronchoalveolar lavage (BAL) was 0.3 +/- 0.07 nmol carbonyl.mL-1 BALF (mean +/- SEM) in the NS control group (n = 9) and tended to be increased, in the asymptomatic S group (n = 8; 0.59 +/- 0.14 nmol.mL-1). This parameter was significantly elevated both in IPF-NS (n = 14; 0.84 +/- 0.2 nmol carbonyl.mL-1 BALF) and SARC-NS (n = 15; 0.73 +/- 0.16 nmol.mL-1) as compared with the NS control. On the contrary, in smoking patients with IPF (n = 6; 0.41 +/- 0.1 nmol carbonyl.mL-1 BALF) and also in ASB-EXS (n = 6; 0.37 +/- 0.06 nmol.mL-1) it was not different from NS controls. The total amount of oxidized proteins correlated positively with the absolute number of eosinophils (EOS) in IPF-NS, IPF-S and SARC, and also with absolute polymorphonuclear neutrophil (PMN) numbers in IPF-NS and IPF-S. In conclusion, oxidative damage of BALF proteins occurred in nonsmoking patients with IPF and SARC. The amount of oxidized bronchoalveolar lavage fluid protein may provide a quantitative assessment of oxygen burden, a balance between oxidant stress and antioxidant defences.
This article has been cited by other articles:

|
 |

|
 |
 
S. Murthy, A. Adamcakova-Dodd, S. S. Perry, L. A. Tephly, R. M. Keller, N. Metwali, D. K. Meyerholz, Y. Wang, M. Glogauer, P. S. Thorne, et al.
Modulation of reactive oxygen species by Rac1 or catalase prevents asbestos-induced pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol,
November 1, 2009;
297(5):
L846 - L855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Ye, Y. Dalavanga, N. Poulakis, S. U. Sixt, J. Guzman, and U. Costabel
Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis
Eur. Respir. J.,
May 1, 2008;
31(5):
1030 - 1036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Piotrowski, A. Antczak, J. Marczak, A. Nawrocka, Z. Kurmanowska, and P. Gorski
Eicosanoids in Exhaled Breath Condensate and BAL Fluid of Patients With Sarcoidosis
Chest,
August 1, 2007;
132(2):
589 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Chen and D. R. Moller
Expression Profiling in Granulomatous Lung Disease
Proceedings of the ATS,
January 1, 2007;
4(1):
101 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Nagai, T Betsuyaku, T Kondo, Y Nasuhara, and M Nishimura
Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid
Thorax,
June 1, 2006;
61(6):
496 - 502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Papageorgiou, K. Kostikas, T. Kiropoulos, E. Karetsi, G. Mpatavanis, and K. I. Gourgoulianis
Increased Oxidative Stress in Exudative Pleural Effusions: A New Marker for the Differentiation Between Exudates and Transudates?
Chest,
November 1, 2005;
128(5):
3291 - 3297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Carter, L. A. Tephly, S. Venkataraman, L. W. Oberley, Y. Zhang, G. R. Buettner, D. R. Spitz, and G. W. Hunninghake
High Levels of Catalase and Glutathione Peroxidase Activity Dampen H2O2 Signaling in Human Alveolar Macrophages
Am. J. Respir. Cell Mol. Biol.,
July 1, 2004;
31(1):
43 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Psathakis, G. Papatheodorou, M. Plataki, P. Panagou, S. Loukides, N. M. Siafakas, and D. Bouros
8-Isoprostane, a Marker of Oxidative Stress, Is Increased in the Expired Breath Condensate of Patients With Pulmonary Sarcoidosis
Chest,
March 1, 2004;
125(3):
1005 - 1011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. KHARITONOV and P. J. BARNES
Exhaled Markers of Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
June 1, 2001;
163(7):
1693 - 1722.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Emad and G. R. Rezaian
Immunoglobulins and Cellular Constituents of the BAL Fluid of Patients With Sulfur Mustard Gas-Induced Pulmonary Fibrosis
Chest,
May 1, 1999;
115(5):
1346 - 1351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. MONTUSCHI, G. C. TONI, P. PAREDI, P. PANTELIDIS, R. M. du BOIS, S. A. KHARITONOV, and P. J. BARNES
8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung Diseases
Am. J. Respir. Crit. Care Med.,
November 1, 1998;
158(5):
1524 - 1527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mateos, J. H Brock, and J. L. Pérez-Arellano
Iron metabolism in the lower respiratory tract
Thorax,
July 1, 1998;
53(7):
594 - 600.
[Full Text]
|
 |
|

|
 |

|
 |
 
J. E. REPINE, A. BAST, I. LANKHORST, and The Oxidative Stress Study Gro
Oxidative Stress in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
July 1, 1997;
156(2):
341 - 357.
[Full Text]
|
 |
|

|
 |

|
 |
 
B. T. MOSSMAN and A. CHURG
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
Am. J. Respir. Crit. Care Med.,
May 1, 1997;
157(5):
1666 - 1680.
[Full Text]
|
 |
|
Copyright © 1996 by the European Respiratory Society.
|